Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis
- PMID: 8840221
- DOI: 10.1007/BF01541225
Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis
Abstract
Interleukin-10 (IL-10) is a major immunoregulatory cytokine and has a multitude of immunomodulatory effects in the immune system. In this study, we have examined the secretion and in vitro function of IL-10 in B cell hyperactivity in antibody production in two common autoimmune diseases, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). IL-10 was detectable in serum of all active SLE and serum and synovial fluid samples of all RA patients but in none of the normal controls. B cells and CD4+CD45RO+ "memory" T cells secreted highly enhanced levels of IL-10 in SLE and RA versus normals. Increased IgM and IgG production by B cells-CD4+CD45RO+ T cells in SLE and RA was IL-10 dependent, since neutralization of IL-10 cytokine by anti-IL-10 antibody drastically reduced Ig synthesis in these coculture experiments. B cell hyperactivity in autoantibody production in SLE and RA may be a function of IL-10-dependent CD4+CD45RO+ Th2 cell activation. Therefore, IL-10 may play an important role in highly disturbed immune system and B cell-T cell function in these immune disorders.
Similar articles
-
Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.Clin Exp Immunol. 2021 Jul;205(1):44-52. doi: 10.1111/cei.13585. Epub 2021 Mar 16. Clin Exp Immunol. 2021. PMID: 33576004 Free PMC article.
-
Interleukin-10 response abnormalities in systemic lupus erythematosus.Scand J Immunol. 1997 Oct;46(4):406-12. doi: 10.1046/j.1365-3083.1997.d01-140.x. Scand J Immunol. 1997. PMID: 9350293
-
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.Cytokine. 2015 Apr;72(2):146-53. doi: 10.1016/j.cyto.2014.12.027. Epub 2015 Jan 31. Cytokine. 2015. PMID: 25647269
-
IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.Semin Immunol. 2019 Aug;44:101330. doi: 10.1016/j.smim.2019.101330. Epub 2019 Nov 15. Semin Immunol. 2019. PMID: 31735515 Review.
-
CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis.Arthritis Rheum. 1990 Aug;33(8):1216-25. doi: 10.1002/art.1780330823. Arthritis Rheum. 1990. PMID: 1975176 Review.
Cited by
-
Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies.Clin Exp Immunol. 2007 Mar;147(3):513-20. doi: 10.1111/j.1365-2249.2006.03313.x. Clin Exp Immunol. 2007. PMID: 17302901 Free PMC article.
-
Cytokines and systemic lupus erythematosus.Ann Rheum Dis. 2000 Apr;59(4):243-51. doi: 10.1136/ard.59.4.243. Ann Rheum Dis. 2000. PMID: 10733469 Free PMC article. Review. No abstract available.
-
Rheumatoid arthritis in Saudi Arabia.Saudi Med J. 2014 Dec;35(12):1442-54. Saudi Med J. 2014. PMID: 25491208 Free PMC article.
-
The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.Clin Exp Immunol. 2001 Apr;124(1):118-25. doi: 10.1046/j.1365-2249.2001.01466.x. Clin Exp Immunol. 2001. PMID: 11359450 Free PMC article.
-
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.Cytokine. 2015 Jul;74(1):27-34. doi: 10.1016/j.cyto.2014.10.031. Epub 2014 Dec 4. Cytokine. 2015. PMID: 25481648 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials